Abstract:Pericoronary adipose tissue (PCAT) plays a critical regulatory role in the initiation and progression of coronary heart disease. Under physiological conditions, PCAT exerts lipid buffering, energy supply and anti-inflammatory protective functions. However, in the setting of metabolic disorders such as obesity and diabetes mellitus, PCAT undergoes functional reprogramming and transforms into a pathological fat depot with pro-inflammatory, pro-oxidative stress and pro-atherosclerotic effects. The fat attenuation index (FAI) derived from coronary computed tomography angiography (CCTA) provides a novel modality for noninvasive assessment of the functional status of PCAT. This review summarizes the molecular mechanisms by which PCAT participates in the progression of coronary atherosclerosis via aberrant lipid metabolism, chronic inflammation, insulin resistance and lymphatic dysfunction, so as to offer new research directions and potential therapeutic targets for the prevention and treatment of coronary heart disease.